These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1947366)

  • 21. Oral corticosteroids for exacerbations of chronic obstructive pulmonary disease.
    Wedzicha JA
    Thorax; 2000 Aug; 55 Suppl 1(Suppl 1):S23-7. PubMed ID: 10943634
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of diltiazem on ventilation in healthy subjects and patients with chronic obstructive pulmonary disease].
    Zeng GB; Duan SF; Zhang ZX
    Zhonghua Nei Ke Za Zhi; 1988 Sep; 27(9):548-50, 587. PubMed ID: 3229193
    [No Abstract]   [Full Text] [Related]  

  • 23. The efficacy of inhaled corticosteroids in the management of non asthmatic chronic airflow obstruction.
    Boothman-Burrell D; Delany SG; Flannery EM; Hancox RJ; Taylor DR
    N Z Med J; 1997 Oct; 110(1053):370-3. PubMed ID: 9364183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sternomastoid muscle fatigue and twitch maximum relaxation rate in patients with steroid dependent asthma.
    Mak VH; Bugler JR; Spiro SG
    Thorax; 1993 Oct; 48(10):979-84. PubMed ID: 8256244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Steroid trials in the assessment of reversibility of air flow limitation.
    Shaheen MZ; Windebank WJ
    Respir Med; 1992 Jan; 86(1):65. PubMed ID: 1565822
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of high dose inhaled beclomethasone dipropionate, 750 micrograms and 1500 micrograms twice daily, and 40 mg per day oral prednisolone on lung function, symptoms, and bronchial hyperresponsiveness in patients with non-asthmatic chronic airflow obstruction.
    Weir DC; Burge PS
    Thorax; 1993 Apr; 48(4):309-16. PubMed ID: 8511727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence of prednisolone induced mood change ('steroid euphoria') in patients with chronic obstructive airways disease.
    Swinburn CR; Wakefield JM; Newman SP; Jones PW
    Br J Clin Pharmacol; 1988 Dec; 26(6):709-13. PubMed ID: 3242575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aerosol beclomethasone in patients with steroid-responsive chronic obstructive pulmonary disease.
    Shim CS; Williams MH
    Am J Med; 1985 Apr; 78(4):655-8. PubMed ID: 3985039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of clorazepate on breathlessness and exercise tolerance in patients with chronic airflow obstruction.
    Eimer M; Cable T; Gal P; Rothenberger LA; McCue JD
    J Fam Pract; 1985 Nov; 21(5):359-62. PubMed ID: 2865326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response to corticosteroids in chronic airflow obstruction: relationship to emphysema and airways collapse.
    Weir DC; Gove RI; Robertson AS; Burge PS
    Eur Respir J; 1991 Nov; 4(10):1185-90. PubMed ID: 1804665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corticosteroid reversibility in COPD is related to features of asthma.
    Chanez P; Vignola AM; O'Shaugnessy T; Enander I; Li D; Jeffery PK; Bousquet J
    Am J Respir Crit Care Med; 1997 May; 155(5):1529-34. PubMed ID: 9154853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Categorisation of ventilatory pattern of response to bronchodilator therapy in airflow limitation.
    Meenakshi S
    J Assoc Physicians India; 1995 Mar; 43(3):179-81. PubMed ID: 11256903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Efficacy of high-dose beclomethasone in patients with stable chronic obstructive pulmonary disease].
    Koyama H; Nishimura K; Ikeda A; Tsukino M; Izumi T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Apr; 33(4):410-5. PubMed ID: 7791269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment.
    Gibson GJ; Prescott RJ; Muers MF; Middleton WG; Mitchell DN; Connolly CK; Harrison BD
    Thorax; 1996 Mar; 51(3):238-47. PubMed ID: 8779124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Residual Volume and Total Lung Capacity to Assess Reversibility in Obstructive Lung Disease.
    McCartney CT; Weis MN; Ruppel GL; Nayak RP
    Respir Care; 2016 Nov; 61(11):1505-1512. PubMed ID: 27555617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of oral prednisolone on response to salbutamol and ipratropium bromide aerosols in patients with chronic airflow obstruction.
    Curzon PG; Martin MA; Cooke NJ; Muers MF
    Thorax; 1983 Aug; 38(8):601-4. PubMed ID: 6225214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pulmonary airflow and beginning obstructive bronchopneumopathies].
    Lacoste J; Uffholtz H; Pham QT; Sentissi M; Berthet A
    Poumon Coeur; 1975; 31(5):263-5. PubMed ID: 1226344
    [No Abstract]   [Full Text] [Related]  

  • 38. Lung hyperinflation and flow limitation in chronic airway obstruction.
    Pellegrino R; Brusasco V
    Eur Respir J; 1997 Mar; 10(3):543-9. PubMed ID: 9072982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between chronic dyspnea and expiratory flow limitation in patients with chronic obstructive pulmonary disease.
    Eltayara L; Becklake MR; Volta CA; Milic-Emili J
    Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1726-34. PubMed ID: 8970362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time course of response to oral and inhaled corticosteroids in non-asthmatic chronic airflow obstruction.
    Weir DC; Robertson AS; Gove RI; Burge PS
    Thorax; 1990 Feb; 45(2):118-21. PubMed ID: 2180106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.